Aaipharma Inc (1013243) SEC Filing 8-K Material Event for the period ending Monday, July 18, 2005

Aaipharma Inc

CIK: 1013243

View differences made from one to another to evaluate Aaipharma Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aaipharma Inc.


Assess how Aaipharma Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aaipharma Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1013243
Form Type: 8-K Corporate News
Accession Number: 0000950144-05-007599
Submitted to the SEC: Fri Jul 22 2005 9:45:35 AM EST
Accepted by the SEC: Fri Jul 22 2005
Period: Monday, July 18, 2005
Industry: Testing Laboratories
  1. Financial Exhibit
  2. New Agreement

External Resources:

Bookmark the Permalink: